Andreas Vitsos

Dr. Andreas Vitsos

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SKStefanos Kikionis
Stefanos Kikionis
MKMarianna Koromvoki
Marianna Koromvoki
ATANNA TAGKA
ANNA TAGKA
EPEleni Polichronaki
Eleni Polichronaki
ASAlexandros Stratigos
Alexandros Stratigos
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Keloids are skin fibroproliferative disorders, resulting from abnormal healing of deep cutaneous injuries. Cryosurgery, the most common treatment for keloids, causes skin traumas. Even though the clinical practice of cryosurgery has increased, effective wound healing therapy is still lacking. In this investigation, nonwoven nanofibrous patches composed of ulvan, a marine sulfated polysaccharide exhibiting anti-inflammatory and antioxidant activities, and polyethylene oxide (PEO) were fabricated through electrospinning and characterized. Their wound healing efficacy on skin traumas resulting from cryosurgical treatment of keloids was clinically tested and evaluated in comparison to a reference product. Twenty-four volunteer patients undergoing cryosurgery as a treatment of keloids were selected to apply either the ulvan/PEO patch or the reference product for 21 days. The ulvan/PEO patch, 21 days after cryosurgery, showed significant wound healing, elimination of skin inflammation, restoration of biophysical parameters similar to normal values and significant decrease in haemoglobin concentration, skin texture and volume, while no discomfort or adverse reaction was observed. In contrast, the reference product showed inferior performance in all evaluated parameters. The designed ulvan/PEO patch represents the first wound dressing to effectively heal skin trauma after cryosurgical treatment of keloids.

21 June 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
ATAsimina Terezaki
Asimina Terezaki
SKStefanos Kikionis
Stefanos Kikionis
Efstathia IoannouEfstathia Ioannou
Efstathia Ioannou
ISIoannis Sfiniadakis
Ioannis Sfiniadakis
Leto-Aikaterini TzivelekaLeto-Aikaterini Tziveleka
Leto-Aikaterini Tziveleka
MRMichail Rallis
Michail Rallis

26 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Aikaterini KyritsiAikaterini Kyritsi
Aikaterini Kyritsi
SKStefanos Kikionis
Stefanos Kikionis
ATAnna Tagka
Anna Tagka
NKNikolaos Koliarakis
Nikolaos Koliarakis
AEAntonia Evangelatou
Antonia Evangelatou
MRMichail Rallis
Michail Rallis
Acute radiodermatitis is the most common side effect in non-melanoma skin cancer patients undergoing radiotherapy. Nonetheless, despite the ongoing progress of clinical trials, no effective regimen has been found yet. In this study, a non-woven patch, comprised of electrospun polymeric micro/nanofibers loaded with an aqueous extract of Pinus halepensis bark (PHBE), was fabricated and clinically tested for its efficacy to prevent radiodermatitis. The bioactivity of the PHBE patch was evaluated in comparison with a medical cream indicated for acute radiodermatitis. Twelve volunteer patients were selected and randomly assigned to two groups, applying either the PHBE patch or the reference cream daily. Evaluation of radiation-induced skin reactions was performed during the radiotherapy period and 1 month afterwards according to the Radiation Therapy Oncology Group (RTOG) grading scale, photo-documentation, patient-reported outcomes (Visual Analog Scale, questionnaire), biophysical measurements (hydration, transepidermal water loss, erythema, melanin), and image analysis. In contrast with the reference product, the PHBE patch showed significant anti-inflammatory activity and restored most skin parameters to normal levels 1 month after completion of radiation therapy. No adverse event was reported, indicating that the application of the PHBE patch can be considered as a safe medical device for prophylactic radiodermatitis treatment.

15 August 2019 in Materials
Verified
Journal Article
Open access
PDF file
EKEleftheria Kotroni
Eleftheria Kotroni
ESEleftheria Simirioti
Eleftheria Simirioti
SKStefanos Kikionis
Stefanos Kikionis
ISIOANNIS SFINIADAKIS
IOANNIS SFINIADAKIS
Angeliki SiamidiAngeliki Siamidi
Angeliki Siamidi
MRMichail Rallis
Michail Rallis
Skin inflammation is the most common symptom in dermatological diseases. It is usually treated by topically applied products, such as creams, gels and lotions. Skin dressings offer a promising alternative as they are endowed with more controlled administration conditions. In this study, the anti-inflammatory activity of electrospun alginate micro/nanofibrous dressings loaded with the aqueous extract of Pinus halepensis bark (PHBE) was evaluated in vivo in mice. The upper back skin of SKH-1 female hairless mice was exposed to a single dose of ultraviolet radiation (3 MEDs) and the inflamed area was treated daily by the direct application of a nanofibrous patch. The condition of the skin was evaluated primarily on the basis of clinical observation, photo-documentation and histopathological assessment, while measurements of the erythema, hydration, transepidermal water loss (TEWL) and sebum production were also taken into account. The results showed that the topical application of alginate micro/nanofibrous dressings loaded with PHBE on UV-inflamed skin significantly attenuated inflammation damage, reducing the healing period. Increase of the loading dose of PHBE resulted in a proportional reduction of the extent, the density and the depth of skin inflammation. With the steadily increasing interest of the skin dressing industry towards nanofibrous matrices, electrospun nonwovens could serve as ideal candidates for the development of multifunctional anti-inflammatory care systems.

Verified
Journal Article
Open access
PDF file
DSDimitra Statha
Dimitra Statha
APAsimina Papaioannou
Asimina Papaioannou
SKStefanos Kikionis
Stefanos Kikionis
MKMaria Kostaki
Maria Kostaki
ISIOANNIS SFINIADAKIS
IOANNIS SFINIADAKIS
MRMichail Rallis
Michail Rallis
The treatment of second-degree burn wounds presents a significant clinical challenge, often characterized by prolonged healing times and risk of complications. In this study, the wound healing potential of bioactive marine sulfated polysaccharides ulvan and carrageenan formulated in gels at concentrations of 1.5%, 5.0%, and 10% w/w was evaluated. Hairless female SKH-hr2 mice (n = 7 per treatment) with burn-inflamed skin were treated with the polysaccharide-based gels, and the therapeutic efficacy was assessed using a comprehensive array of evaluation methods, including a histopathological analysis, clinical observation, photo-documentation, an image analysis, an evaluation of biophysical skin parameters, and FT-IR spectroscopy. Our findings indicate that the 10% w/w carrageenan gel exhibited significant enhancement in wound healing, particularly in the early stages of the healing process. This was evidenced by the restoration of the α-helix structure of collagen and the configuration of glycosaminoglycans, as demonstrated by FT-IR absorption bands of the skin both in vivo and ex vivo. Furthermore, the 5% w/w ulvan gel also demonstrated notable efficacy in promoting wound healing, particularly in the later stages of the healing process. These results suggest that carrageenan and ulvan gels hold promise for improving the efficiency of wound healing in second-degree burn wounds. Our study contributes to the understanding of the therapeutic potential of marine polysaccharides and provides insights into their mechanism of action in promoting wound healing.

15 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MGMaria Giakoumaki
Maria Giakoumaki
George I LambrouGeorge I Lambrou
George I Lambrou
DVDimitris Vlachodimitropoulos
Dimitris Vlachodimitropoulos
ATANNA TAGKA
ANNA TAGKA
AVAndreas Vitsos
Andreas Vitsos
Homer Selton BlackHomer Selton Black
Homer Selton Black
This study explores the previously uncharted territory of the effects of ultraviolet (UV) radiation on diabetic skin, compared to its well-documented impact on normal skin, particularly focusing on carcinogenesis and aging. Employing hairless SKH-hr2, Type 1 and 2 diabetic, and nondiabetic male mice, the research subjected these to UV radiation thrice weekly for eight months. The investigation included comprehensive assessments of photoaging and photocarcinogenesis in diabetic versus normal skin, measuring factors such as hydration, trans-epidermal water loss, elasticity, skin thickness, melanin, sebum content, stratum corneum exfoliation and body weight, alongside photo documentation. Additionally, oxidative stress and the presence of hydrophilic antioxidants (uric acid and glutathione) in the stratum corneum were evaluated. Histopathological examination post-sacrifice provided insights into the morphological changes. Findings reveal that under UV exposure, Type 1 diabetic skin showed heightened dehydration, thinning, and signs of accelerated aging. Remarkably, Type 1 diabetic mice did not develop squamous cell carcinoma or pigmented nevi, contrary to normal and Type 2 diabetic skin. This unexpected resistance to UV-induced skin cancers in Type 1 diabetic skin prompts a crucial need for further research to uncover the underlying mechanisms providing this resistance.